Skip to Main text


About Us

About Us

The Nitto Group strives to become a centennial company that is always trusted by customers, embraced by employees with pride, makes an active contribution to society, and continuously grows on a global scale.

What's New RSS

The Nitto website is currently under system maintenance. Please try again later.
2018/Nov/29 Nitto announces Phase I clinical trial of NBF-006 for the treatment of KRAS driven tumors in advanced cancer patients is allowed to proceed by the FDA
2018/Oct/25 100th anniversary greetings
2018/Sep/28 Nitto Supports Reconstruction from the 2018 Hokkaido Eastern Iburi earthquake

Back to Page Top